+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Global Hyperkalemia Drugs Market 2022-2026 - Product Thumbnail Image

Global Hyperkalemia Drugs Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
From
From
Global Hyperkalemia Supplement Market 2021-2027 - Product Thumbnail Image

Global Hyperkalemia Supplement Market 2021-2027

  • Report
  • January 2022
  • 126 Pages
From
Hyperkalemia Market: A Research Perspective - Product Thumbnail Image

Hyperkalemia Market: A Research Perspective

  • Report
  • February 2020
  • 19 Pages
From
From
From
From
From
From
Iron Drugs - Global Market Trajectory & Analytics - Product Thumbnail Image

Iron Drugs - Global Market Trajectory & Analytics

  • Report
  • April 2021
  • 184 Pages
From
From
From
From
Loading Indicator